Young-Min Han

Title: Young-Min Han: Innovator in Cancer Treatment

Introduction

Young-Min Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the creation of novel obovatol derivatives that have the potential to inhibit cancer cell growth and induce apoptosis.

Latest Patents

Young-Min Han holds a patent for "Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient." This patent discloses novel obovatol derivatives represented by Chemical Formula 1, along with their pharmaceutically acceptable salts. These compounds are designed to be effective in preventing and treating cancer, as well as suppressing cancer metastasis.

Career Highlights

Young-Min Han is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has led to advancements in the pharmaceutical industry, particularly in the development of cancer therapies. His innovative approach and dedication to research have positioned him as a key figure in the fight against cancer.

Collaborations

Young-Min Han has collaborated with notable colleagues, including Byoung-Mog Kwon and Dong Cho Han. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.

Conclusion

Young-Min Han's contributions to cancer treatment through his innovative patents and research are commendable. His work exemplifies the importance of innovation in the medical field, particularly in the ongoing battle against cancer.